| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910462693103321 |
|
|
Autore |
Gahima Gerald |
|
|
Titolo |
Transitional justice in Rwanda : accountability for atrocity / / Gerald Gahima |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Abingdon, Oxon ; ; New York : , : Routledge, , 2013 |
|
|
|
|
|
|
|
ISBN |
|
0-203-07515-3 |
1-299-16067-0 |
1-135-11854-X |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (433 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
War crime trials - Rwanda |
Transitional justice - Rwanda |
Gacaca justice system - Rwanda |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Theoretical framework of transitional justice -- A decade of atrocities -- Accountability for mass atrocity challenges choices and goals of transitional justice in rwanda -- Accountability, justice and the role of the International Criminal Tribunal for Rwanda -- National prosecutions -- Seeking alternative accountability mechanisms -- Trials based on universal jurisdiction -- Untold story, unfinished business - confronting the crimes of the victors -- Assessing the impact and legacy of Rwanda's processes of accountability for atrocity -- Tentative lessons from Rwanda's mechanisms of accountability for atrocity -- Conclusion. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Transitional Justice in Rwanda: Accountability for Atrocity comprehensively analyzes the full range of the transitional justice processes undertaken for the Rwandan genocide. Drawing on the author's extensive professional experience as the principal justice policy maker and the leading law enforcement officer in Rwanda from 1996-2003, the book provides an in-depth analysis of the social, political and legal challenges faced by Rwanda in the aftermath of the genocide and the aspirations and legacy of transitional justice. The |
|
|
|
|
|
|
|
|
|
|
|
|
|
book explores the role played by the accountability proce |
|
|
|
|
|
|
2. |
Record Nr. |
UNISALENTO991003001899707536 |
|
|
Autore |
Findlay, John Niemayer |
|
|
Titolo |
Hegel oggi : un riesame del sistema hegeliano in rapporto alle idee e al linguaggio del nostro tempo / John Niemeyer Findlay ; a cura di Lorenzo Calabi |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Hegel, Georg Wilhelm Friedrich |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910633917403321 |
|
|
Titolo |
Neuroimaging Pharmacopoeia / / edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[2nd ed. 2022.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (413 pages) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium |
|
|
|
|
|
|
|
|
|
|
|
Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil. |
|
|
|
|
|
|
Sommario/riassunto |
|
This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. . |
|
|
|
|
|
|
|
| |